NCT06446167

Brief Summary

This study aims to evaluate the effectiveness of exercise combined with ESWT (Extracorporeal Shockwave Therapy), exercise combined with MLS (Multiwave Locked System) laser therapy, and exercise alone in female patients diagnosed with unilateral plantar fasciitis, using Visual Analog Scale (VAS), Heel Tenderness Index (HTI), Foot and Ankle Outcome Score (FAOS), Foot Function Index (FFI) and fall risk, as clinical parameters to assess any differences in effectiveness levels among these treatments.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2021

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 29, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 29, 2022

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

June 1, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 6, 2024

Completed
Last Updated

June 6, 2024

Status Verified

June 1, 2024

Enrollment Period

12 months

First QC Date

June 1, 2024

Last Update Submit

June 1, 2024

Conditions

Keywords

Plantar FasciitisExerciseLasersExtracorporeal Shockwave Therapy

Outcome Measures

Primary Outcomes (1)

  • Visual Analog Scale (VAS)

    VAS is a scale 10 cm in length, starting from "no pain" and ending with "unbearable pain" (0: no pain, 10: unbearable pain). Patients indicate the severity of their pain by marking the appropriate point on this scale. The distance between "no pain" and this marked point is measured and recorded in centimeters

    one month

Secondary Outcomes (4)

  • Foot Function Index (FFI)

    one month

  • Foot and Ankle Outcome Score (FAOS)

    one month

  • Heel Tenderness Index (HTI)

    one month

  • Biodex Fall Risk Assessment

    one month

Study Arms (3)

Exercise group

ACTIVE COMPARATOR

All groups received a regimen of daily exercises, including stretches for the plantar fascia and Achilles tendon, and strengthening exercises for the calf muscles and foot intrinsic muscles. Each type of exercise was demonstrated to the participants by the same physiotherapist at the beginning of the treatment process, to be performed twice a day with 10 repetitions each time.

Other: Exercises

Laser group

ACTIVE COMPARATOR

The MLS Laser applied to the treatment group was administered using an ASA brand Mphi model device. Patients in the Laser group were positioned in a prone position. Treatment was applied continuously for 7 minutes along the plantar fascia, sole of the foot, heel area, and Achilles tendon in accordance with the plantar fasciitis treatment program on the device, at a dose of 1.73 J/cm2 and a frequency of 700 Hz. A treatment program was established with 3 sessions per week, totaling 10 sessions. Patients receiving laser therapy also continued with their exercise programs.

Other: ExercisesOther: MLS Laser Treatment

ESWT group

ACTIVE COMPARATOR

The treatment group was administered with the Swiss DolorClast Master ESWT device, which produces radial shock waves. Patients in the ESWT group were positioned in a prone position. The most painful point in the heel area was identified through palpation. Gel was applied to this area, followed by the surrounding soft tissues, towards the plantar fascia and the attachment area of the Achilles tendon at the dorsal aspect of the heel. Radial ESWT treatment was applied at a frequency of 10 Hz, pressure of 2.5 bars, and 2000 impulses per session, once a week for a total of 4 sessions. Patients receiving ESWT therapy also continued with their exercise programs.

Other: ExercisesOther: ESWT treatment

Interventions

All groups received a regimen of daily exercises, including stretches for the plantar fascia and Achilles tendon, and strengthening exercises for the calf muscles and foot intrinsic muscles. Each type of exercise was demonstrated to the participants by the same physiotherapist at the beginning of the treatment process, to be performed twice a day with 10 repetitions each time.

ESWT groupExercise groupLaser group

The MLS Laser applied to the treatment group was administered using an ASA brand Mphi model device. Patients in the Laser group were positioned in a prone position. Treatment was applied continuously for 7 minutes along the plantar fascia, sole of the foot, heel area, and Achilles tendon in accordance with the plantar fasciitis treatment program on the device, at a dose of 1.73 J/cm2 and a frequency of 700 Hz. A treatment program was established with 3 sessions per week, totaling 10 sessions

Laser group

The treatment group was administered with the Swiss DolorClast Master ESWT device, which produces radial shock waves. Patients in the ESWT group were positioned in a prone position. The most painful point in the heel area was identified through palpation. Gel was applied to this area, followed by the surrounding soft tissues, towards the plantar fascia and the attachment area of the Achilles tendon at the dorsal aspect of the heel. Radial ESWT treatment was applied at a frequency of 10 Hz, pressure of 2.5 bars, and 2000 impulses per session, once a week for a total of 4 sessions

ESWT group

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age between 18-65 years
  • Female gender
  • Symptoms persisting for at least 6 weeks
  • Unilateral plantar fasciitis
  • Consent to participate in the study

You may not qualify if:

  • Male gender
  • Bilateral plantar fasciitis
  • Treatment with ESWT, laser or injection therapy for plantar fasciitis in the previous year
  • Participation in a physical therapy program for plantar fasciitis in the last six months
  • History of systemic inflammatory disease
  • History of lower extremity fracture or surgery
  • Pregnancy
  • History of epilepsy
  • Malignancy
  • Active infection
  • Coagulation disorders
  • Severe cardiac disease or history of pacemaker
  • History of neuromuscular disease affecting balance parameters
  • Regular use of nonsteroidal antiinflammatory drugs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

İstanbul Medipol University

Istanbul, 34200, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Fasciitis, PlantarMotor Activity

Interventions

Exercise

Condition Hierarchy (Ancestors)

FasciitisMusculoskeletal DiseasesFoot DiseasesBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • İbrahim Ethem Kirez

    İstanbulSBÜ

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The evaluation of outcomes was performed by an assessor blinded to the treatment allocation.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: 60 patients met the eligibility criteria and were enrolled in the study. The eligible participants were randomized into three distinct groups each comprising 20 individuals: an exercise alone group (Exercise group), an exercise combined with MLS laser therapy group (Laser group), and an exercise combined with ESWT group (ESWT group). Randomization was conducted using a computer-assisted program
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Specialist Doctor

Study Record Dates

First Submitted

June 1, 2024

First Posted

June 6, 2024

Study Start

May 1, 2021

Primary Completion

April 29, 2022

Study Completion

April 29, 2022

Last Updated

June 6, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations